Sertraline oral concentrate
AssigneePfizer Inc.
InventorsNancy J. Harper, Gautam R. Ranade, Willard M. Welch
Life of this patent
Estimating the term…
Loading patent…
AssigneePfizer Inc.
InventorsNancy J. Harper, Gautam R. Ranade, Willard M. Welch
Estimating the term…
The present invention provides an essentially nonaqueous, liquid pharmaceutical concentrate composition for oral administration containing sertraline or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The present invention also provides a use of this concentrate composition to prepare an aqueous solution of sertraline. In addition, the present invention provides a method of using this concentrate composition to treat or prevent a variety of diseases or conditions. Finally, the present invention provides the compound, (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine methanesulfonate.
A pharmaceutical composition which comprises;
Dependencies are inferred from the claim text.